V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158361 | 20060629 | 1.61 | 65.5 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100843446 |
| 20158363 | 20060630 | 1.82 | 119 | Curative (C) | 2018-03-10 | 2018-03-15 | ECX | N | N | ECX | 101199360 |
| 20158364 | 20060631 | 1.78 | 85.7 | Adjuvant (A) | 2016-09-19 | 2016-10-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100990579 |
| 20158368 | 20060632 | null | null | Palliative (P) | 2016-11-07 | 2016-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101270641 |
| 20158370 | 20060633 | 1.66 | 67.15 | Palliative (P) | 2019-09-10 | 2019-09-18 | ECX | N | null | ECX | 100315348 |
| 20158373 | 20060634 | 1.62 | 82.7 | Neo-adjuvant (N) | 2017-08-25 | 2017-09-04 | ECX | N | N | ECX | 101194415 |
| 20158375 | 20060635 | null | null | Palliative (P) | 2016-12-18 | 2017-01-09 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100012012 |
| 20158377 | 20060636 | 1.62 | 69 | Palliative (P) | 2016-09-28 | 2016-10-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100244912 |
| 20158378 | 20060637 | 1.78 | null | Adjuvant (A) | 2019-03-11 | 2019-03-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100405749 |
| 20158379 | 20060638 | 1.67 | 50.8 | Palliative (P) | 2016-05-22 | 2016-05-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100498451 |
| 20158380 | 20060639 | 1.77 | 55 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100399962 |
| 20158382 | 20060640 | 1.75 | 61.5 | Palliative (P) | 2017-03-25 | 2017-03-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101671035 |
| 20158383 | 20060641 | 1.76 | 75.1 | Palliative (P) | null | 2019-01-04 | ECX | null | N | ECX | 101499181 |
| 20158385 | 20060642 | 1.61 | 82.3 | Palliative (P) | 2018-08-17 | 2018-08-20 | ECX | 2 | N | ECX | 100765008 |
| 20158387 | 20060643 | 1.73 | 82.6 | Neo-adjuvant (N) | 2019-06-30 | 2019-07-02 | ECX | N | null | ECX | 101682222 |
| 20158388 | 20060644 | null | 85 | Neo-adjuvant (N) | 2018-04-27 | 2018-04-27 | ECX | 02 | N | ECX | 100251393 |
| 20158391 | 20060645 | 1.79 | 66 | Curative (C) | 2018-11-16 | 2018-11-29 | ECX | 02 | Y | ECX | 101403505 |
| 20158393 | 20060646 | 1.58 | 54.9 | Neo-adjuvant (N) | 2016-08-11 | 2016-08-25 | ECX | N | N | ECX | 100422979 |
| 20158396 | 20060647 | 1.5 | 58 | Palliative (P) | 2017-07-08 | 2017-09-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100972624 |
| 20158397 | 20060648 | 1.91 | 72.2 | Adjuvant (A) | 2018-12-11 | 2018-12-14 | ECX | N | N | ECX | 100985570 |
| 20158399 | 20060649 | 1.8 | 98.8 | Palliative (P) | 2018-10-10 | 2018-10-10 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101094139 |
| 20158400 | 20060650 | 1.63 | 58.6 | Neo-adjuvant (N) | 2018-04-05 | 2018-04-27 | ECX | N | N | ECX | 100494685 |
| 20158401 | 20060651 | 1.67 | 81 | Curative (C) | 2018-06-25 | 2018-06-30 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101208025 |
| 20158403 | 20060652 | 1.73 | 89.6 | Neo-adjuvant (N) | 2018-08-12 | 2018-08-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100099833 |
| 20158404 | 20060653 | 1.67 | 108 | null | 2018-07-03 | 2018-07-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101846190 |
| 20158405 | 20060654 | 1.77 | 68.5 | Palliative (P) | 2017-12-14 | 2018-01-01 | ECX | N | N | ECX | 100132734 |
| 20158406 | 20060655 | 1.75 | 72 | Adjuvant (A) | 2017-03-21 | 2017-03-22 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100942695 |
| 20158409 | 20060656 | 1.72 | 75.1 | Palliative (P) | 2018-03-18 | 2018-04-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100841928 |
| 20158412 | 20060657 | 1.72 | 82.45 | Adjuvant (A) | 2016-05-29 | 2016-06-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100850373 |
| 20158415 | 20060658 | 1.68 | 66.7 | Neo-adjuvant (N) | 2016-09-24 | 2016-10-10 | ECX | N | N | ECX | 100530319 |
| 20158418 | 20060659 | 1.67 | 66.3 | Curative (C) | 2019-02-27 | 2019-03-14 | ECX | N | N | ECX | 100721812 |
| 20158419 | 20060660 | 1.64 | 90 | Adjuvant (A) | 2019-03-15 | 2019-03-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100104659 |
| 20158420 | 20060661 | 1.81 | 73.35 | Neo-adjuvant (N) | 2019-08-08 | 2019-08-09 | ECX | 02 | N | ECX | 101274300 |
| 20158421 | 20060662 | 1.71 | 69.5 | Neo-adjuvant (N) | 2018-07-21 | 2018-07-22 | ECX | 2 | N | ECX | 101659782 |
| 20158423 | 20060663 | 1.8 | 42.7 | Curative (C) | 2019-03-17 | 2019-03-26 | ECX | N | N | ECX | 101798575 |
| 20158424 | 20060664 | 1.85 | 58.1 | Palliative (P) | 2017-11-24 | 2017-11-28 | ECX | N | N | ECX | 101176637 |
| 20158425 | 20060665 | 1.67 | 59.4 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-24 | ECX | N | N | ECX | 101016805 |
| 20158426 | 20060666 | 1.8 | 80 | null | 2018-12-20 | 2018-12-28 | ECX | 2 | null | ECX | 101673700 |
| 20158427 | 20060667 | 1.58 | 80 | Neo-adjuvant (N) | 2019-11-29 | 2019-12-08 | ECX | null | Y | CAPECITABINE + GEMCITABINE | 101696180 |
| 20158428 | 20060668 | 1.53 | 52.8 | Palliative (P) | 2018-07-21 | 2018-07-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101262829 |
| 20158430 | 20060669 | 1.8 | 85.5 | Adjuvant (A) | 2017-08-31 | 2017-10-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100757913 |
| 20158431 | 20060670 | null | 79.2 | Palliative (P) | 2018-01-27 | 2018-02-15 | ECX | N | N | ECX | 101753668 |
| 20158432 | 20060671 | 1.59 | 65.7 | Neo-adjuvant (N) | null | 2016-04-08 | ECX | N | N | ECX | 100061871 |
| 20158435 | 20060672 | 1.6 | 52.9 | Palliative (P) | 2018-02-02 | 2018-02-18 | ECX | N | null | ECX | 100174246 |
| 20158442 | 20060673 | 1.63 | 51.5 | Adjuvant (A) | 2016-08-14 | 2016-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100331652 |
| 20158444 | 20060674 | 1.64 | 100.9 | Palliative (P) | 2019-01-03 | 2019-01-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100280685 |
| 20158445 | 20060675 | 1.78 | 83.5 | Curative (C) | 2017-10-19 | 2017-11-07 | ECX | N | N | ECX | 100947156 |
| 20158447 | 20060676 | 1.76 | 86.7 | Neo-adjuvant (N) | 2019-06-26 | 2019-07-08 | ECX | 2 | N | ECX | 100896914 |
| 20158448 | 20060677 | 1.71 | 77 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-13 | ECX | N | N | ECX | 100560247 |
| 20158453 | 20060678 | 1.63 | 50 | Neo-adjuvant (N) | 2018-09-07 | 2018-10-12 | ECX | N | N | ECX | 101804837 |